Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (100.0%)Evaluating the Efficacy of Opti-Speech for Speech Treatment
Not Applicable
Completed
- Conditions
- DysarthriaArticulation DisorderPrelingual Deafness
- First Posted Date
- 2016-03-10
- Last Posted Date
- 2018-12-31
- Lead Sponsor
- Vulintus, Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT02705326
- Locations
- 🇺🇸
The Cleveland Hearing and Speech Center, Cleveland, Ohio, United States
🇺🇸Callier Center for Communication Disorders at UT Dallas, Richardson, Texas, United States
News
No news found